B Cell News and Research

RSS

Clemson scientists improve longevity of fluorescent nanoparticles

Clemson University chemists have developed a method to dramatically improve the longevity of fluorescent nanoparticles that may someday help researchers track the motion of a single molecule as it travels through a living cell.

22 Aug 2007

New Cockayne syndrome discovery

Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have shown that the genetic defect that causes Cockayne Syndrome affects a key function of the cell – the transcription of genes coding for ribosomal RNA.

21 Aug 2007

Natural protection provides possible new treatments for stroke

Two substances that occur naturally in the brain act to protect the brain during a stroke. This is the conclusion of a dissertation published at the Sahlgrenska Academy, and the discovery may lead to new treatments for stroke patients.

21 Aug 2007

Critical blood shortage in southeastern Michigan

The American Red Cross Southeastern Michigan Blood Services Region is issuing an urgent appeal for blood donors. Recent extraordinary patient needs and consistent low donor turnout this month have caused the local blood supply to drop to critically low levels.

21 Aug 2007

Red and blue fruits and veggies the best for fighting cancer

A new study by scientists in the U.S. has found that red and blue foods are the best when it comes to fighting cancer.

20 Aug 2007

We need to treat cancer like an infectious disease

Among the many medical miracles produced by science over the years, vaccines and antibiotics have undoubtedly saved the most lives.

17 Aug 2007

Drug topotecan shows promise against Wilms tumor

St. Jude researchers have shown that the drug topotecan holds promise as a treatment for the recurrent form of a kidney cancer called Wilms tumor, a solid tumor of the kidney that arises from immature kidney cells, and the fifth most common tumor among children.

17 Aug 2007

Proteins involved in fragile X syndrome identified

The interplay of two proteins that bind to messenger RNA, a molecule that mediates translation of the information encoded in genes into proteins, triggers the appearance of fragile X-associated tremor/ataxia syndrome (FTAX), a late-life disorder associated with the gene that causes fragile X syndrome in children, said researchers from Baylor College of Medicine in Houston and Emory University School of Medicine in a report that appears today in the journal Neuron.

17 Aug 2007

New understanding of how HSV-1 attacks cells

A team of University of Kentucky researchers has identified the roles that herpes simplex virus type 1 (HSV-1) proteins play during the invasion of cells and the formation of skin lesions known as cold sores and fever blisters.

17 Aug 2007

Reactivating a critical gene lost in kidney cancer reduces tumor growth

Researchers at Mayo Clinic Jacksonville, have found that a key gene is often silenced in clear cell renal cell carcinoma, the most common type of kidney cancer, and when they restored that gene in human kidney cancer cells in culture and animal experiments, tumors stopped growing and many disappeared.

17 Aug 2007

Prophylactic cranial irradiation in small cell lung cancer significantly increases survival

Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer (SCLC), according to the results of the multicenter phase III randomized EORTC trial 08993-22993, published in the New England Journal of Medicine.

17 Aug 2007

Antibacterial soaps show no health benefits over plain soaps

Antibacterial soaps show no health benefits over plain soaps and, in fact, may render some common antibiotics less effective, says a University of Michigan public health professor.

17 Aug 2007

Scientists discover new mechanism for viral replication

Researchers at the University of Pennsylvania School of Medicine have identified a new strategy that Kaposi's Sarcoma Associated Herpesvirus (KSHV) uses to dupe infected cells into replicating its viral genome.

17 Aug 2007

New target for the development of anti-influenza drugs

Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.

17 Aug 2007

B Cell News and Research

Clemson scientists improve longevity of fluorescent nanoparticles

New Cockayne syndrome discovery

Natural protection provides possible new treatments for stroke

Critical blood shortage in southeastern Michigan

Red and blue fruits and veggies the best for fighting cancer

We need to treat cancer like an infectious disease

Drug topotecan shows promise against Wilms tumor

Proteins involved in fragile X syndrome identified

New understanding of how HSV-1 attacks cells

Reactivating a critical gene lost in kidney cancer reduces tumor growth

Prophylactic cranial irradiation in small cell lung cancer significantly increases survival

Antibacterial soaps show no health benefits over plain soaps

Scientists discover new mechanism for viral replication

New target for the development of anti-influenza drugs

New prion protein 'Shadoo' discovered - may offer insight into mad cow disease

Sirtuin protein instrumental in fat production and metabolism

Low levels of key protein may indicate pancreatic cancer risk

Researchers discover how a protein modulates the inflammatory response in acute respiratory distress syndrome

HIV protein both causes brain injury and prevents its repair

New findings on cholesterol metabolism

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News